Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCloudtag Inc Regulatory News (CTAG)

  • There is currently no data for CTAG

Further re Tranche 2 Notes

3 Jan 2017 07:00

RNS Number : 1263T
CloudTag Inc.
03 January 2017
 

3 January 2017

 

 

CloudTag Inc.

("CloudTag" or the "Company")

 

Notice of drawdown issued in respect of second part of the Tranche 2 Notes

 

CloudTag (CTAG:LN), the company that brings personal monitoring to the wellbeing, fitness and digital health markets, confirms that after business hours on 30 December 2016 it issued to L1 a Notice of Drawdown for the remainder of the second part of the Tranche 2 Notes being £1 million of nominal value of which the Company expects to receive £850,000 net of expenses. Under the terms of the Notes, 2 business days' notice is required prior to the funds being due to the Company following which the Notes will be issued to L1. A further announcement will be made when the funds are received and the Notes issued.

 

Definitions used in this notification are taken from the Company's announcement dated 7 November 2016 and the Company's circular to shareholders dated 24 November 2016.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

CloudTag Inc.

Amit Ben-Haim / Tony Reeves

+1 345 949 45 44

contact@cloudtag.com

UK Investor Relations

+44 (0) 20 7052 8469investors@cloudtag.com

Cairn Financial Advisers LLP (Nominated Adviser)

Liam Murray / Jo Turner

+44 (0) 20 7213 0880

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FUREAFFAELEXEAF
Date   Source Headline
5th Sep 201611:00 amRNSSecond Price Monitoring Extn
5th Sep 20169:05 amRNSSecond Price Monitoring Extn
5th Sep 20169:00 amRNSPrice Monitoring Extension
2nd Sep 20164:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20164:35 pmRNSPrice Monitoring Extension
2nd Sep 20164:02 pmRNSMovement in Share Price and Update
16th Aug 201611:16 amRNSHolding(s) in Company
10th Aug 20167:00 amRNSFundraise of £580,000
8th Aug 20167:00 amRNSBinding Heads of Terms Signed with US Partner
5th Aug 20161:28 pmRNSCorrection: Holding(s) in Company
4th Aug 20164:08 pmRNSHolding(s) in Company
1st Aug 20167:00 amRNSAppointment of Chief Creative Officer
18th Jul 20165:13 pmRNSHolding(s) in Company
14th Jul 201611:32 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSFundraise of £800,000
12th Jul 20167:00 amRNSIssue of Equity
6th Jul 20167:00 amRNSGrant of Options and Warrants
5th Jul 20164:40 pmRNSSecond Price Monitoring Extn
5th Jul 20164:35 pmRNSPrice Monitoring Extension
1st Jul 20164:10 pmRNSHolding(s) in Company
28th Jun 20167:00 amRNSHalf-year Report
22nd Jun 20161:10 pmRNSHolding(s) in Company
16th Jun 20167:00 amRNSOperational Update & Subscription for £470,000
15th Jun 20164:21 pmRNSHolding(s) in Company
9th Jun 20167:00 amRNSCommercial Update and Subscription
31st May 201610:07 amRNSMovement in Share Price
10th May 201610:06 amRNSHolding(s) in Company
3rd May 20167:00 amRNSFundraising £50,000 & Conversion of Loan Notes
29th Apr 20164:48 pmRNSIssue of Equity
26th Apr 20164:03 pmRNSResult of AGM
12th Apr 20163:59 pmRNSCorrection: Fundraise of £171,430
11th Apr 20167:00 amRNSFundraise of £171,430
7th Apr 20164:58 pmRNSHolding(s) in Company
5th Apr 20166:01 pmRNSFundraise of £60,000
31st Mar 20167:00 amRNSHolding(s) in Company
30th Mar 20165:23 pmRNSPosting of Annual Report
30th Mar 20167:00 amRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSFundraise of £112,000
23rd Mar 20167:00 amRNSFinal Results
21st Mar 20167:00 amRNSFundraise of £225,400
16th Mar 201611:03 amRNSFundraise of £228,000
16th Mar 20169:28 amRNSHolding(s) in Company
7th Mar 20167:00 amRNSFundraise of £65,000
29th Feb 20164:19 pmRNS£215,000 Fundraising
25th Jan 20167:00 amRNSUS$5.2 Million Distribution Agreement
22nd Jan 20167:00 amRNSISPO Exhibition
21st Jan 20167:00 amRNS£250,000 Fundraising
15th Jan 20167:00 amRNSOperational Update & Convertible Loan Facility
6th Jan 20168:03 amRNSFirst Product Launch
31st Dec 20157:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.